Skip to Main Content

WASHINGTON — Purdue Pharma, the embattled opioid maker, has quietly split ways with PhRMA, the powerful lobbying organization charged with representing the drug industry in Washington.

The break is the latest demonstration that the drug maker, which has filed for bankruptcy and is inundated by lawsuits across the country for its role in marketing OxyContin, is retreating from attempts to influence federal drug policy or restore its reputation.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • If only all self-serving, unscrupulously abusive, and fully greed-fired drug companies would follow suit, the Big Pharma Lobbyist Machine would become extinct. When that is accomplished, mark that glorious day as a new National Holiday – for everyone in the US !! Of course Purdue’s lobby-stop is lack-of-money related – but who cares?

Comments are closed.